Munn, 43, revealed that the score prompted her physician to recommend further evaluations, which ultimately led to the discovery of cancer in both of her breasts, even after a negative mammogram and genetic tests.

Munn's Instagram post explained that her risk-assessment score revealed a lifetime risk of 37%, raising concerns for her healthcare provider. As a result, Munn underwent an MRI, followed by an ultrasound and biopsy, which confirmed the presence of Luminal B cancer in both breasts. This type of cancer is known for its aggressive and fast-moving nature.

Breast cancer risk assessment tools are widely used by patients and physicians to predict the likelihood of developing invasive breast cancer. One such tool is the breast cancer risk assessment tool (BCRAT), also known as the Gail Model. This assessment takes about five minutes to complete and estimates the risk of developing breast cancer over a specified age range.

Factors such as age, race, medical history, reproductive history, and family history of breast cancer among first-degree relatives are considered when calculating the risk score. A BCRAT score of 1.67% or higher within a five-year timeframe is categorized as high-risk, potentially leading to recommendations for preventive measures.

Dr. Nicole Saphier, a board-certified breast imaging radiologist and associate professor at Memorial Sloan Kettering Cancer Center, emphasized the importance of individual risk assessments based on factors like breast density and other risk factors. Saphier stated that Munn's doctor's decision to go beyond a standard mammogram potentially saved her life.

Dr. Ruth Oratz, a breast medical oncologist at NYU Langone Health's Perlmutter Cancer Center, recommended that patients who discover an increased risk of breast cancer through self-assessments should discuss this with their physicians. Factors such as family history may prompt further evaluation, including genetic testing, to determine the patient's specific risk profile for breast and other types of cancer.

Breast cancer specialist Dr. Elisa Port noted that the risk of breast cancer can vary significantly among women, with the average woman having a risk ranging from 10% to 12%. However, Munn's case serves as a reminder that even individuals with seemingly low risk should be vigilant in monitoring their health and considering risk-assessment options.

Munn's revelation sheds light on the role of breast cancer risk-assessment scores in early detection and prevention. By leveraging these tools, healthcare providers can identify high-risk individuals and recommend additional screenings or preventive measures. This highlights the importance of personalized risk assessments and ongoing dialogue between patients and physicians to ensure early detection and successful treatment outcomes.

Disclaimer: The information presented in this article is based solely on the statements made by Olivia Munn and medical experts mentioned. It is advised to consult with healthcare professionals for personalized advice and information regarding breast cancer risk assessment.